Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001737287-18-000001
Filing Date
2018-04-19
Accepted
2018-04-19 12:02:56
Documents
1
Effectiveness Date
2018-04-19
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 12638
  Complete submission text file 0001737287-18-000001.txt   13694
Mailing Address 689 5TH AVENUE 12TH FLOOR NEW YORK NY 10022
Business Address 689 5TH AVENUE 12TH FLOOR NEW YORK NY 10022 212-871-7920
Allogene Therapeutics, Inc. (Filer) CIK: 0001737287 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-310557 | Film No.: 18762914